How have our grey seals adapted to eat venomous weever fish? – The Irish Times

Ireland can boast one of the least toxic terrains on the planet, at least for people. With the exception of a few deadly mushrooms, which are avoidable, the most poisonous wildlife drifts in from outside notably a few stinging jellyfish.

Few if any of our fellow mammals in Ireland have needed to evolve ways of eating other, venomous, creatures. In the rest of the world at least 3O mammals are known to have developed biochemical defences that negate a poison or numb response to pain.

That could be said, I suppose, about Irelands badgers and pine martens, attacking bees and wasps nests for grubs. But our hedgehogs, unlike some of those in continental Europe, do not include scorpions or vipers in their prey.

All this makes it more intriguing that some Irish grey seals may specialise in eating the venomous weever fish, Echiichthys vipera, whose piercing of any human foot can prove extremely painful.

Wintering at the moment in near-hibernation in deeper, warmer water at perhaps 150 metres, the hand-size lesser weever returns to the shallows in early summer, burrowing into the sand and resting there with just its eyes and the tip of its black dorsal fin exposed. Its ambition is the ambush of little fish such as blennies and gobies with a dart of its upward-pointing mouth.

It is also equipped to punish anything that tries to eat it, or otherwise presses on its venomous dorsal spines. It can stay buried as the tide recedes and wait in the sand until the water comes back.

Fear of the weever would occasionally haunt my own childhood paddling on the intertidal sands of Sussex. The memory was revived a year or two ago when Mayo surfers at nearby Carrowniskey began writing agitated blogs about the apparent concentration of weevers on that strand.

On the rare occasions when it is plentiful, one expert wrote, rows of erect black triangles decorate the sand floor of the seabed.

Something like that may have supplied the remarkable appetite of some seals for weevers reported in Biology and Environment, the journal of the Royal Irish Academy. The discovery is a spin-off from a study by four researchers at UCC, led by Dr Martha Gosch, examining the diet of grey seals for potential impact on commercial fisheries.

This entailed gathering some 150 seal scat (droppings, faeces) from sand banks at Raven Point in Wexford Harbour used as a haul-out by up to 300 animals. Collected between cleansing tides and across two years, the scats were unlikely to repeat offerings from the same individuals.

Weever remains, including the bony otoliths of the inner ear (a standard identification of fish), were found in 4 per cent of the droppings, including one scat with remains of 76 of them, plus one sign of flatfish. The relatively high abundance of weever in a limited number of scats, the study concluded, was some evidence for specialisation.

It also suggested that the seals had developed a way of eating the fish without suffering from the venom. The skin inside a seals mouth and oesophagus is not especially thick compared with that of the leatherback turtle, which regularly eats jellyfish with toxic stings. Grey seals tend to eat fish whole, suggesting that they may have learned to gulp weevers head first, helping to push the poison spine flat.

Seals themselves figure among specialised choices of prey. Wildlife films have shown spectacular and chilling sequences of killer whales (orcas) killing seals, surging onto beaches to drag them into the sea on the southern coast of Argentina or ganging up to make waves that wash Arctic seals off ice floes.

Given the abundance of seals off Ireland and Scotland, this has me wondering why the orcas two separate groups with seven or eight in each have seemed to leave them alone.

Some genetic research on orcas, including those of the north Atlantic, suggests that their small social groups have created cultures of hunting that are genetically inherited. Some, more nomadic, groups are seal eaters while others hunt fish and seabirds off particular coasts. The orcas that commute between west Scotland and Ireland are well-known as fish eaters, though others have been filmed eating harbour porpoises off Scotland.

At Shetland last September, orcas were videoed flipping a harbour seal pup into the air, like the playful assassins of Argentina. And new research from the University of Aberdeen potentially links the orcas to a dramatic decline in numbers of Scotlands harbour seals, with numbers in Orkney and Shetland dropping by 40 per cent in five years.

Unlike the grey seals, which pup in late autumn, the smaller harbour seals pup in June and July, the months when most orca sightings are reported to the Irish Whale and Dolphin Group. The last harbour seal surveys, almost two decades ago, found more than 4,000 of them around Irelandcoasts. It may soon seem appropriate to count them again.

See the rest here:
How have our grey seals adapted to eat venomous weever fish? - The Irish Times

Prenatal Biochemical Screening and a Womans Long-Term Risk of Cancer: A Population-Based Cohort Study. – Physician’s Weekly

Some hormones measured in pregnancy are linked to certain hormone-sensitive cancers. We investigated whether routine serum screening in pregnancy is associated with a womans subsequent risk of hormone-sensitive cancer.This population-based cohort study included women aged 12-55years who underwent prenatal screening between 11 weeks + 0 days of gestation to 20 weeks + 6 days of gestation in Ontario, Canada, 1993-2011, where universal health care is available. The hazard ratio of newly diagnosed breast, ovarian, endometrial, and thyroid cancer-arising at 21 weeks + 0 days of gestation or thereafter-was estimated in association with an abnormally low (5th) or high (>95th) percentile multiple of the median (MoM) for alpha-fetoprotein (AFP), total human chorionic gonadotropin (hCG), unconjugated estriol, pregnancy-associated plasma protein A, and dimeric inhibin A.Among 677247 pregnant women followed for a median of 11.0years (interquartile range = 7.5-16.1), 7231 (1.07%) developed breast cancer, 515 (0.08%) ovarian cancer, 508 (0.08%) endometrial cancer, and 4105 (0.61%) thyroid cancer. In multivariable adjusted models, abnormally high hCG greater than the 95th percentile MoM was associated with a doubling in the risk of endometrial cancer (adjusted hazard ratio [aHR] = 1.98, 95% confidence interval [CI] = 1.33 to 2.95), and abnormally low AFP at the fifth percentile or less MoM conferred a moderately greater risk of thyroid cancer (aHR = 1.21, 95% CI = 1.07 to 1.38). Abnormally low pregnancy-associated plasma protein A at the fifth percentile or less MoM was not statistically significantly associated with breast cancer after multivariable adjustment (aHR = 1.19, 95% CI = 0.98 to 1.36).Women with abnormally high levels of serum hCG or low AFP in early pregnancy may be at a greater future risk of certain types of hormone-sensitive cancers. The Author(s) 2020. Published by Oxford University Press.

View original post here:
Prenatal Biochemical Screening and a Womans Long-Term Risk of Cancer: A Population-Based Cohort Study. - Physician's Weekly

Postdoc Position, Department of Biology job with MASARYK UNIVERSITY | 193197 – Times Higher Education (THE)

POSTDOC POSITION in Characterization of factors involved in metabolism of stalled replication forks and their possible disease relevance

Department Department of BiologyFaculty of Medicine

Deadline 29 Feb 2020

Start date March/April 2020 or upon agreement but no later than by 30th November 2020

Masaryk University, Brno, Czech Republic invites excellent scientists to apply for POSTDOC POSITION in Characterization of factors involved in metabolism of stalled replication forks and their possible disease relevance

Description:

The integrity of DNA continually resists the presence of physical and chemical carcinogens in our environment. In addition to exogenous agents, DNA undergoes spontaneous decay, including replication errors, oxidative and other damages which arise from common metabolic processes. The repair of damaged DNA is vital for the maintenance of genome integrity, and as aresult, all organisms have evolved awide variety of DNA repair pathways that can restore DNA structure and its genetic information.

The main objective of our research is to decipher the intrinsic functions of homologous recombination (HR) which has adual role in the maintenance of genome stability. First, it promotes the faithful repair of DNA double-strand breaks (DSBs) belonging among of the most lethal forms of DNA damage. Moreover, HR is responsible for the creation of genetic variability during meiosis by directing the formation of reciprocal crossovers that result in random combinations of alleles and traits. Changes in the execution and regulation of recombination are linked to human infertility, miscarriage and genetic diseases, particularly cancer thus emphasizing the importance of better understanding the mechanism and regulation of this pathway.

To achieve our goals, we utilize awide range of different methods from biochemistry, molecular biology, genetics, structural biology, and biophysics that are well established in our lab. Since we believe that interdisciplinary approach is needed to fully understand the fundamental biological processes, we also collaborate with numerous specialists.

The successful candidate should:

Specific criteria can be filled, i.e.:

The application should include:

MU offers the opportunity to get:

Anticipated start date:The position is available from March/April 2020 or upon agreement but no later than by 30th November 2020.

The submission deadline is29th February 2020.

Please submit your application by e-mail tovrablikova@med.muni.cz

Areview of applications will commence immediately after the deadline. Short-listed candidates will be invited for interview within one month of the deadline.

Further information about:

prof. MUDr. Martin Repko, Ph.D.dkan

Visit link:
Postdoc Position, Department of Biology job with MASARYK UNIVERSITY | 193197 - Times Higher Education (THE)

The biology of coffee, the world’s most popular drink – Times Colonist

This article was originally published on The Conversation, an independent and nonprofit source of news, analysis and commentary from academic experts. Disclosure information is available on the original site.

___

Author: Thomas Merritt, Professor and Canada Research Chair, Chemistry and Biochemistry, Laurentian University

You're reading this with a cup of coffee in your hand, aren't you? Coffee is the most popular drink in the world. Americans drink more coffee than soda, juice and tea combined.

How popular is coffee? When news first broke that Prince Harry and Meghan were considering Canada as their new home, Canadian coffee giant Tim Hortons offered free coffee for life as an extra enticement.

Given coffee's popularity, it's surprising how much confusion surrounds how this hot, dark, nectar of the gods affects our biology.

The main biologically active ingredients in coffee are caffeine (a stimulant) and a suite of antioxidants. What do we know about how caffeine and antioxidants affect our bodies? The fundamentals are pretty simple, but the devil is in the details and the speculation around how coffee could either help or harm us runs a bit wild.

The stimulant properties of caffeine mean that you can count on a cup of coffee to wake you up. In fact, coffee, or at least the caffeine it contains, is the most commonly used psychoactive drug in the world. It seems to work as a stimulant, at least in part, by blocking adenosine, which promotes sleep, from binding to its receptor.

Caffeine and adenosine have similar ring structures. Caffeine acts as a molecular mimic, filling and blocking the adenosine receptor, preventing the body's natural ability to be able a rest when it's tired.

This blocking is also the reason why too much coffee can leave you feeling jittery or sleepless. You can only postpone fatigue for so long before the body's regulatory systems begin to fail, leading to simple things like the jitters, but also more serious effects like anxiety or insomnia. Complications may be common; a possible link between coffee drinking and insomnia was identified more than 100 years ago.

Different people respond to caffeine differently. At least some of this variation is from having different forms of that adenosine receptor, the molecule that caffeine binds to and blocks. There are likely other sites of genetic variation as well.

There are individuals who don't process caffeine and to whom drinks like coffee could pose medical danger. Even away from those extremes, however, there is variation in how we respond to that cup of coffee. And, like much of biology, that variation is a function of environment, our past coffee consumption, genetics and, honestly, just random chance.

We may be interested in coffee because of the oh-so-joyous caffeine buzz, but that doesn't mean that caffeine is the most biologically interesting aspect of a good cup of coffee.

In one study using rats, caffeine triggered smooth muscle contraction, so it is possible that caffeine directly promotes bowel activity. Other studies, though, have shown that decaffeinated coffee can have as strong an effect on bowel activity as regular coffee, suggesting a more complex mechanism involving some of the other molecules in coffee.

What about the antioxidants in coffee and the buzz that surrounds them? Things actually start out pretty straightforward. Metabolic processes produce the energy necessary for life, but they also create waste, often in the form of oxidized molecules that can be harmful in themselves or in damaging other molecules.

Antioxidants are a broad group of molecules that can scrub up dangerous waste; all organisms produce antioxidants as part of their metabolic balance. It is unclear if supplementing our diet with additional antioxidants can augment these natural defences, but that hasn't stopped speculation.

Antioxidants have been linked to almost everything, including premature ejaculation.

Are any of the claims of positive effects substantiated? Surprisingly, the answer is again a resounding maybe.

Coffee won't cure cancer, but it may help to prevent it and possibly other diseases as well. Part of answering the question of coffee's connection to cancer lies in asking another: what is cancer? At its simplest, cancer is uncontrolled cell growth, which is fundamentally about regulating when genes are, or are not, actively expressed.

My research group studies gene regulation and I can tell you that even a good cup of coffee, or boost of caffeine, won't cause genes that are turned off or on at the wrong time to suddenly start playing by the rules.

The antioxidants in coffee may actually have a cancer-fighting effect. Remember that antioxidants fight cellular damage. One type of damage that they may help reduce is mutations to DNA, and cancer is caused by mutations that lead to the misregulation of genes.

Studies have shown that consuming coffee fights cancer in rats. Other studies in humans have shown that coffee consumption is associated with lower rates of some cancers.

Interestingly, coffee consumption has also been linked to reduced rates of other diseases as well. Higher coffee consumption is linked to lower rates of Parkinson's disease and some other forms of dementia. Strikingly, at least one experimental study in mice and cell culture shows that protection is a function of a combination of caffeine and antioxidants in coffee.

Higher coffee consumption has also been linked to lower rates of Type 2 diabetes. Complexity, combined effects and variation between individuals seems to be the theme across all the diseases.

At the end of the day, where does all this leave us on the biology of coffee? Well, as I tell my students, it's complicated. But as most reading this already know, coffee will definitely wake you up in the morning.

___

This article is republished from The Conversation under a Creative Commons license. Disclosure information is available on the original site. Read the original article:

https://theconversation.com/the-biology-of-coffee-the-worlds-most-popular-drink-129179

Read the rest here:
The biology of coffee, the world's most popular drink - Times Colonist

Notre Dame senior Nicole Butler named the national Army ROTC student of the year – ND Newswire

Notre Dame senior Nicole Butler (second from right) reacts to the announcement during ESPN2 program College Football Live, that she won the Army ROTC student of the year as fellow cadets congratulate her in the Middlefield Commons at the Duncan Student Center. Photo by Barbara Johnston/University of Notre Dame.

University of Notre Dame senior Nicole Butler has been selected as the nations Army ROTC student of the year and to the ROTC All-American Team, an awards program now in its second year that honors the best and brightest ROTC seniors across the country.

I was thrilled to learn of Nicoles selection, said Rev. John I. Jenkins, C.S.C., Notre Dames president. The attributes recognized by the award her leadership, military excellence, scholarship and service will serve her well as she completes her Notre Dame education and begins her military career. Notre Dame has a long, proud history with ROTC, and outstanding students like Nicole are part of the reason why. I join with her family, friends, fellow cadets and the ROTC faculty and staff in offering my sincere congratulations.

Butler knew she was a finalist but did not know she was selected as the top Army ROTC student until Thursday afternoon (Dec. 12), when it was revealed during the ESPN2 program College Football Live.

This whole experience has been amazing, Butler said after the announcement. Its been humbling to have the support of everyone in our battalion.

Butler is from Spring, Texas, and will graduate in May with dual degrees in Arabic and biochemistry. She was selected from a group of 12 finalists who:

Air Force and Navy students of the year also were recognized. Butler and the two other top students will receive $6,500 scholarships, and their units will receive a $5,000 donation. The winners also will be honored Dec. 27 at the Military Bowl at the U.S. Naval Academy in Annapolis, Maryland.

In a slightly different format last year, Notre Dames Kirsten Cullinan was recognized as the Air Force ROTC student of the year.

The program is sponsored by Navy Federal Credit Union.

Go here to read the rest:
Notre Dame senior Nicole Butler named the national Army ROTC student of the year - ND Newswire

An Alzheimer’s research pioneer, right here at Penn – Penn: Office of University Communications

A primary project for Garrett Gibbons, a postdoctoral researcher at the Center for Neurodegenerative Disease Research (CNDR), is to develop novel tau antibodies as possibletherapies to treat Alzheimers disease. When in the thick of it, the scientific process becomes a huge, timelyand sometimes redundanttask.

One particular experiment comes to mind: Gibbons and his colleagues were injecting tau into mice models, which the mice developed antibodies against, and when they were harvested, the cells were paired with another cell to make a hybridoma. The problem? After two times running the full experiment, the antibodies still didnt meet certain criteria to be applicable.

Gibbons, quite disheartened, told his adviserVirginia Man-Yee Lee, a Perelman School of Medicine professor and director of CNDR, that the benchmark was too high.

Virginia was like, Well, try again, Gibbons recalled. She pushed back and said how she thought we could do better.

Although admittedly frustrated at the time, Gibbons rethought the project, and, ultimately, underwent a revamped test a third time.

And we got better antibodies, performing better than the previous ones, he said. They are now the candidates that we are evaluating as immunotherapy in mice, as potential treatments for Alzheimers disease.

It is safe to say, noted Gibbons, that without this kind of persistence from Lee, Alzheimers research wouldnt be nearly as developed as it is today. A pioneer in the field of neurodegenerative diseases, Lee was recently recognized for her four decades of work with a $3 million Breakthrough Prize in Life Sciences, an award backed by major technology leaders from companies including Google and Facebook.

Growing up in Hong Kong in a very traditional Chinese family, my mother never wanted me to become a professional, let alone a scientist, Lee said to the crowd, while accepting her Breakthrough Prize at the Oscars of Science in Silicon Valley in early November. Thankfully John Trojanowski, my life partner and collaborator, convinced me to embark on this wonderful journey with him, identifying proteins that are involved in devastating neurological diseases, which affect more and more of us, but have no effective treatment.

Lee, with a background in biochemistry and neuroscience, and Trojanowski, who studied pathology and neuropathology, have toiled alongside each other at Penn since the mid-1980s. They began work in Alzheimers research when it was very uncommon to do soin fact, their mentors urged them to stay far, far away from it.

What [our mentors] saw as a swamp, said Trojanowski, we saw as a huge challenge and opportunity that has led to an engaging career.

Before Lee and Trojanowski, prior studies had determined that an Alzheimers patients brain progressively accumulates plaques, abnormal clusters of protein fragments called beta-amyloid, that build up between nerve cells, and tangles, which form inside dying cells. Using this as a starting point, the duo detected their first major finding in 1991: that tau is the building block protein of the neurofibrillary tangles.

In 1997, Lee and Trojanowski found that Lewy bodies, the hallmark brain pathology of Parkinsons disease, are formed by alpha-synuclein. Knowing what causes Lewy bodies is important to Alzheimers researchers because about 50 percent of Alzheimers patients have Lewy bodies that contribute to cognitive deficits.

Then, in 2006, they discovered the pathological protein deposits in amyotrophic lateral sclerosis, or ALS, and frontotemporal degeneration, or FTD, are formed by TDP-43, a multifunctional DNA- and RNA-binding protein, and these deposits are also present in a large number of Alzheimers patients brains.

Lee was specifically recognized for the Breakthrough Prize for discovering TDP-43 protein aggregates in FTD and ALS, and revealing that different forms of alpha-synuclein, in different cell types, underlie Parkinsons disease and Multiple System Atrophy.

This is exceptionally important work, and we are very proud that it is taking place at Penn. Penn President Amy Gutmann

The discoveries led by Dr. Lee and her team are extraordinary, and absolutely worthy of the prestigious Breakthrough Prize, said Penn President Amy Gutmann, who went to Silicon Valley to support Lee in receiving her honor. Dr. Lee and her team have worked to fully understand the different segments of Alzheimers disease and other related disorders, using that knowledge to develop models that are becoming the foundation for therapies that will, hopefully, stop or reverse these diseases. This is exceptionally important work, and we are very proud that it is taking place at Penn.

Its rewarding, Lee said, to reflect on how researchers are becoming increasingly interested in TDP-43s involvement in neurodegenerative diseases, and the biology that is able to follow, now.

It is gratifying that people can, and people are very interested in, using the system that weve built to identify potential therapies, Lee explained. I am really optimistic that maybe some treatment for Alzheimers and Parkinsons will become available in the next, lets say, one or two decades.

Gibbons, who can distinctly remember being a teenager and watching his grandfather cope with all the stages of Alzheimers, as well as the impact it had on his family, knew rather early it would be a field he would want to pursue. But, it wasnt until he was immersed in the research that he realized how complicated it really was.

When I first got to Penn, I was kind of blown away with the challenge and sort of became cynical and pessimistic, Gibbons said. But I like the way that Dr. Lee continues to forge ahead and isnt overwhelmed as a young investigator, that gives me a lot of inspiration and hope. Of course there will be failures, and of course science is hard. This is worthwhile, and we will get there.

In terms of Lee as a leader, Mike Henderson, a research associate in her lab, said he appreciates the way she guides him in his learning, but also provides him with the independence needed to encourage innovative, out-of-the box thinking.

She really shows you what it takes to be a good scientist in the field, he said, adding how inquisitive Lee always is. Shes very curious and I think thats really what has driven her lab and what has made her so successful.

The main reason Henderson came to Penn, he noted, was to work not only with Lee and Trojanowski, but also with the team theyve assembled through the creation of the CNDR, which celebrated its 25th year in 2018. About 50 people are part of the center today.

From the Maloney Building on Penns campus, where CNDR is housed, Lee and Trojanowski have been able to foster multidisciplinary collaborations between basic and clinical scientists, and provide resources to enable the very best research projects, including a brain and biosample bank, a drug discovery program, data management and biostastic support, and expertise in biochemistry, histology, molecular biology, microscopy, tissue culture, and genetics.

John and I spent a lot of time developing an infrastructure to do this type of work, and Penn has been such a fantastic environment, said Lee, who acknowledged all of her collaboratorsstudents, postdocs, and staff scientistsat the Breakthrough event. I truly want to thank them for their dedication and commitment, she said.

Talking later, Trojanowski added, They have made possible all that we have accomplished.

There is no doubt about it: Talking about his beloved wife of 40-plus years is probably one of Trojanowskis favorite things to do. Shes always pushing herself to be better, and shes always pushing me to be better. She is driven, hardworking, very bright, determinedall of the things that you expect to see and need to see in people that are going to be as successful as she is.

Not only is she passionate about science, he adds, shes determined to solve any problem she ever sets her eyes on. Plus, shes an amazing preceptor, trainer, encourager of science in young people. She is just exceptional, he added.

Trojanowski attended the Breakthrough event with his wife, thrilled to stand by her side on such an exciting day. Its an outstanding recognition, he said.

One might think a $3 million check in the bank could be a ticket out of work, but for Lee, she was back in Philadelphia after just a couple days. As always, she rode her bike to the officeready and willing to take on her next challenge.

What Id like to do in the next 10 to 20 years, Lee said, is really work with companiespharmaceutical companies and biotechnology companiesto come up with treatments.

Virginia Man-Yee Lee is the John H. Ware 3rd Endowed Professor in Alzheimers Research in the Department of Pathology and Laboratory Medicinein the Perelman School of Medicine.

John Q. Trojanowski is the William Maul Measey - Truman G. Schnabel, Jr., M.D. Professor of Geriatric Medicine and Gerontology in the Department of Pathology and Laboratory Medicinein the Perelman School of Medicine.

The Breakthrough Prize in Life Sciences, founded in 2013, honors transformative advances toward understanding living systems and extending human life. It is sponsored by Sergey Brin, Priscilla Chan and Mark Zuckerberg, Pony Ma, Yuri and Julia Milner, and Anne Wojcicki.

Homepage photo: Today, about 50 people make up the Center for Neurodegenerative Disease Research, led by Lee and Trojanowski, who both expressed how thankful they are for such a great team.

See the original post:
An Alzheimer's research pioneer, right here at Penn - Penn: Office of University Communications

Artist Sarah Sze on Working With Neuroscientists – Columbia University

In her lab, where she works with flies, Rudy Behnia focuses on how the human brain sees the world and distinguishes colors and emotions, revealing complex sensory information. One of the metrics she uses is the flicker fusion rate, which is the frequency in which we perceive flicker. If we're looking at a screen, we don't see the flicker, but a fly has a higher flicker fusion rate than ours and sees the screen flickering in frames.

In my paintings, I think of perception in terms of hue, color or tone, yet I hadn't thought of it in terms of speed. After spending time with Rudy,I started a video piece that plays with the perception of image intensity and velocity, incorporating this fracturing, a speeding up or slowing down of shutters. When discussing the evolution of fly vision, Rudy explained how an insects eye perceives color during the day and black and white at night, and how the transition between these two states falls at dusk and dawn.

Ive also been focused on dusk and dawn for a largepublic project Im doing at LaGuardia Airport. The work tracks time through images of the sky, and is framed at either edge by images of dusk and dawn. Where night is, the work disappears.

Read more:
Artist Sarah Sze on Working With Neuroscientists - Columbia University

Longhorn Stop the Bleed receives 5 years of funding to expand emergency response training – UT The Daily Texan

The previously unfunded Longhorn Stop the Bleed program recently received five years of funding from Campus Safety and Security.

The program is a chapter of a national organization created after Sandy Hook to teach people how to respond in bleeding emergencies. UT alumna Claire Zagorski said she started a chapter of the program on campus to reduce fatality and helplessness.

I was inspired to bring it to UT after Harrison Brown was stabbed to death, program director Zagorski said. The bystander was saying, This is terrible because he was laying there bleeding and no one could do anything, just wait. Im a paramedic, and I knew that wasnt true, but I also knew people had to be taught what to do.

Zagorski said the funding will consist of $2,500 every year and is the result of safety advocacy nonprofit SafeHorns stressing the programs importance to Campus Safety and Security.

It was very validating, Zagorski said. Im glad that the work that were doing is getting noticed and that were making a difference, and now were going to be able to take a big step forward in expanding the program because of that.

Zagorski said the program will use the funds to buy more training equipment for larger classes and to launch a promotional campaign to increase awareness. She said the training is useful in many contexts, but people pay attention to the program if they see a recent uptick in campus violence.

UT is an open campus, biochemistry sophomore Sonia Patel said. I think its a necessity for people, and students especially, to be aware of what to do in the event of a shooting or stabbing. If we were aware of it, we could help save people.

Zagorski said the program partners with the certified EMTs in Longhorn EMS to lead training courses. David Wu, lead instructor of Longhorn Stop the Bleed in Longhorn EMS, said empowerment is a huge goal of the training.

It isnt necessarily having the skills, biochemistry junior Wu said. Its having the confidence of knowing you have the training to know what to do in that scenario. Most bystanders are in shock when something happens, and with a little training, it gives you a bit of confidence to go, Okay, I know what to do in this situation. This is how I should move forward.

Link:
Longhorn Stop the Bleed receives 5 years of funding to expand emergency response training - UT The Daily Texan

Biochemical Sensor Market Size in Terms of Volume and Value – Crypto News Byte

The competition prevailing in the global biochemical sensor market is considerably high. As leading companies fight out for the lead in the market, product innovations and launches are on cards. Besides this, investments in research and development have scaled higher as market players aim for emerging at the fore. In order to boost operations, several players are concentrating on expanding their regional footprint, especially in Asia Pacific. Cheap labor, abundance of raw materials, and the rising demand from emerging nations make the region highly lucrative for investment, finds Trends market research(TMR) in a Recent study.

Some of the most prominent names in the global biochemical sensor market are GE Healthcare, Thermo Fisher Scientific, Honeywell International, Inc., Bio-Rad Laboratories, Inc., and Polestar Technologies, Inc., among others. Besides aforementioned strategies, many of the market players are also pushing mergers and acquisitions to capitalize on their expertise and expand their product portfolio.

Overall, the globalbiochemical sensor marketwill rise at a healthy CAGR of XX% by 2025. At this pace, the market is expected to reach US$XX bn by the end of 2025, from its valuation of US$XX bn in 2016. Based on product, electrochemical sensors constituted the leading segment with a share of XX% in 2016. Besides this, piezoelectric sensor, thermal sensor, gas sensor, and optical sensor make other key segments in terms of product.

Request For Report sample @:https://www.trendsmarketresearch.com/report/sample/3433

Regionally, North America held dominant with a share of over XX% in the global market in 2018. Europe and Asia Pacific followed closely as the second- and third-leading markets for biochemical in the same year. However, over the course of the forecast period, North America is likely to lose its market share, while Asia Pacific and Europe markets will witness accelerated pace of gains.

Application across Diverse Industries, Especially Healthcare, to Boost Growth

As biochemical sensors have found a leading end user in the healthcare sector, growth witnessed in the industry will subsequently fuel their demand. The healthcare infrastructure is a major consideration by governments when planning economic growth. Over the years, the industry has expanded exponentially. Additionally, investments in research and development are forecast to increase in the coming years.

Request Report For Toc:https://www.trendsmarketresearch.com/report/requesttoc/3433

Biochemical sensors are used in the qualitative and quantitative assessment of clinical diagnosis in the healthcare sector, said a lead TMR analyst. The increasing aging population, coupled with the rising incidence of chronic ailments, will fuel the demand for precise diagnosis, thus providing significant impetus to the biochemical sensor market, he added.

Besides this, government initiatives to ensure superior food quality, advancements in material chemistry and wireless networks, the rising demand for advanced wearable biochemical sensors, and the growing population of point of care diagnostics will create lucrative market opportunities. RRI also prophesized that the rising oil extraction worldwide will tip scales in favor of the market. Rise in oil extraction would result in greater percentage of inflammable and toxic in the air. Spurred by this, the use of biochemical sensors will increase to detect the presence of toxic gas.

Full View ofReport Description:https://www.trendsmarketresearch.com/report/biochemical-sensor-market

Originally posted here:
Biochemical Sensor Market Size in Terms of Volume and Value - Crypto News Byte

Alternative Medicine and Clinical Laboratory Practice – American Association for Clinical Chemistry (AACC)

The Complementary and Alternative Medicine (CAM) marketincluding everything from yoga and meditation to acupuncture and naturopathyis projected to be worth $210.12 billion by 2026, according to Grand View Research.

CAM practitioners often order the same clinical laboratory tests as traditional physicians, and with blood drawn by laboratories like Quest, LabCorp, and some hospitals, said Jaquel Patterson, ND, president of the American Association of Naturopathic Physicians (AANP) and owner of Fairfield Family Health in Fairfield, Connecticut. She mentioned specialized rheumatology assays from reference labs as an example of how she uses clinical laboratory testing.

But some specialty tests that naturopathic practitioners order are not available from local clinical laboratories, which she hopes will change. Its hard to get in relationships with a lab to do courtesy draws, she said.

The challenge for naturopaths? Many clinical laboratory professionals are wary of playing a role in what many see as an unregulated, belief-based system of medicine.

Twenty-two states, plus Washington D.C., Puerto Rico, and the U.S. Virgin Islands regulate naturopathic practitioners. According to the AANP, naturopathic practitioners in these states must fulfill state-mandated continuing education requirements annually and have a specific scope of practice as defined by their states law.

A study published in Annals of Clinical Biochemistry looked at how laboratory tests are commonly used in CAM in the U.S., U.K., and Australia (Ann Clin Biochem 2019 May;56:310-25). Little to no data have been published about which tests are ordered most often, according to the lead author of this paper, Stuart Jones, MSc, FRCPath, consultant clinical biochemist in the department of clinical biochemistry at King Georges Hospital in London. But the most widely available that he has come across in his work include IgG antibodies for food intolerance, nutritional or metabolic profiles, and tests for heavy metal toxicity.

Often, laboratories specializing in CAM perform these tests. To meet the growing demand for CAM testing, a number of small reference laboratories around the world now offer specialty testing specifically marketed to naturopathic providers. Some operate entirely outside of any recognized accreditation program while others are accredited to the standard of established clinical laboratories, said Jones. Some CAM practitioners also offer some of their own tests directly to the public.

There are some CAM practitioners that will use established, validated tests in an appropriate way, but what we have found is that there seems to be a preference in this community for using unvalidated or even discredited tests, often to justify potentially unnecessary treatments and therapies, he said.

This isnt surprising, said Britt Marie Hermes, a PhD student at the University of Kiel in Germany and a former naturopathic doctor who writes about the industry at naturopathicdiaries.com. There is a large degree of variability with regard to how licensed naturopaths practice, she said. Some naturopaths may order and interpret lab tests according to established medical standards, but, based on having worked as a naturopath for several years and having practiced alongside many naturopaths, I can say from personal experience that naturopaths do not use lab tests like medical doctors.

Hermes said this is important for clinical laboratorians to know, and that they should be aware that naturopaths are providing patients with information that conflicts with information put out by medical professionals, she said. She gave as an example the issue that naturopaths will use different criteria to diagnose disease and make medical treatment recommendations.

In their study of CAM laboratories and testing, Jones and his co-authors also note that in the U.S., surveyors from the Centers for Medicare and Medicaid Services no longer routinely inspect CLIA-waived laboratories, which represent thousands of small testing sites.

The authors also point out that CLIA certification requires laboratories to meet standards in a variety of areas including staff qualifications, proficiency testing and test accuracy, reliability, and timeliness. It does not require demonstration of clinical validity and utility. Thus, CAM laboratories in the U.S. can be CLIA certified while offering tests that are neither clinically valid nor clinically useful.

Michael Astion, MD, PhD, medical director in the department of laboratories at Seattle Childrens Hospital and a clinical professor of laboratory medicine at the University of Washington, said he encounters CAM often, usually through parents who consult naturopaths or other CAM practitioners in addition to seeking medical treatment for their children. I think they have a role in the healthcare system, he said. There is some fraud and abuse there, but its not that common in laboratory services. He mostly sees CAMs using traditional laboratory tests, and not over-ordering.

Hes more concerned about tests that go beyond the scope of traditional medicine and how those tests are interpreted. Thats especially true with tests that are done at specialty laboratories. In general the problem with those labs is that tests tend to come back positive because the thresholds for positivity are very low, he said.

One example: hair analysis. Hair is not very good [as an analyte] for anything except maybe arsenic, and thats only good in the hands of some very excellent labs, Astion said. Its a very difficult specimen but CAM labs will do all kinds of toxicity testing on hair that come back with fairly alarming reports. Two other concerning tests are for allergies and food sensitivity. These are tests that youd never see a normal allergist or board-certified gastroenterologist order, he said.

His second concern is the overuse of screening tests and the ordering of very large panels. When you apply the wellness movement to laboratory medicine, you make everybody sick, he said, which is followed by treatments for diseases that arent there.

Requests for urinalysis for heavy metals is also a problem. Everyone is going to have some metals in their urine if they receive a heavy metal chelator, Astion said, but this doesnt mean that theyre sick. That doesnt mean you can eat a bag of fertilizer or drink a can of Raid, but it does mean you can probably use Raid in your house occasionally, and you can fertilize your lawn and, you can paint your house, he said.

Astion doesnt think that CAM practitioners are bad people or trying to make their patients sick, but that many are operating outside the scope of their knowledge. He likens it to the popularity of total body computed tomography scanning businesses in the early 2000s. If I image you from the top of your head to the bottom of your toes, youll have a lot of anomalies. That doesnt mean that theyre disease causingmost of them are not, he said. Thats why all those places closed. They were telling all these people they were sick, which led them to having unnecessary procedures. Thats exactly what happens when you get outside of the scope of your practice.

When patients bring in requests to have blood drawn for CAM testing, Astion said his institution typically refuses and gives parents an information sheet that says we do patient-centered testing. We do not do patient directed testing, he said. We dont judge them. We treat them just like if you came into my Italian restaurant and ordered Japanese food, he said. You can have Japanese food, but you cant have it here.

He will also ask CAM practitioners to stop requesting those kinds of blood draws from his hospital and give them information for a reference laboratory that might work with them. The message to CAM practitioners is, that order doesnt make sense to us. We practice conventional medicine, Astion said. Im not criticizing you, but I dont want to be party to it. Use another lab.

Jen A. Miller is a freelance journalist who lives in Audubon, New Jersey.+TWITTER:@byJenMiller

Original post:
Alternative Medicine and Clinical Laboratory Practice - American Association for Clinical Chemistry (AACC)

Welcome | Department of Biochemistry | The School of …

Biochemistry at Illinois has a long tradition of excellence in biochemical research. Many of our undergraduate and graduate students as well as postdoctoral research associates have used their experiences at Illinois to establish careers of responsibility in both academia and the private sector.

I hope that you will take the time to explore our department by investigating our undergraduate and graduate programs so that you can learn about the intellectual opportunities now possible by breakthroughs in this postgenomic era of biology. The future of biochemistry has changed, and we believe that our department is well-positioned to provide training for your future.

Milan Bagchi, Interim Head

A career spanning six decades, over 400 papers, 25 graduate students, and numerous awards surely means a relaxing retirement? Not quite. Govindjee, at 86 years, is still dissecting the mechanisms of photosynthesis. He also collaborates with researchers across the globe to improve crops for food and energy production.

The Zhang lab recently published a paper in Cell Chemical Biology titled "Optogenetic delineation of receptor tyrosine kinase subcircuits in PC12 cell differentiation."

Our fall issue of the MCB magazine focuses on the diverse ways in which microbes affect our health.

See the article here:
Welcome | Department of Biochemistry | The School of ...

Bicycle Therapeutics Announces Appointment of Veronica Jordan, Ph.D., to Board of Directors – Business Wire

CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, today announced the appointment of Veronica Jordan, Ph.D., to its Board of Directors, where she will serve as Chair of the Compensation Committee. Dr. Jordan was a corporate director for more than 15 years, with extensive experience in the biopharmaceutical industry, and has been an advisor to companies developing novel healthcare products.

Veronica is an accomplished international business leader who has expertise across diverse corporate functions, including clinical operations, business development, and corporate governance, said Kevin Lee, Ph.D., Chief Executive Officer of Bicycle. We believe that her valuable insight into these areas will be key to our success as we continue to advance our clinical pipeline and execute against our goals as a public company. I am pleased to welcome Veronica to Bicycles Board.

Since 2007, Dr. Jordan has served as an independent consultant to healthcare companies and contract research organizations and as Managing Director of Golden Seeds, an angel investor network. She was previously CEO and President of Medelle Corporation, a private medical device company, and held various executive roles at PAREXEL International during her 14 years on the companys management team. Dr. Jordan has been a member of the Board of Directors of Vermillion, Inc. since 2014 and currently serves as Chair of the Compensation Committee and a member of the Audit Committee. From 2006 to 2016, she was a Director of Albany Molecular Research, Inc. Dr. Jordan earned a B.A. in biochemistry from Cambridge University and a Ph.D. in biochemistry and cell biology from Oxford University.

About Bicycle Therapeutics

Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycles, for diseases that are underserved by existing therapeutics. Bicycles are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycles attractive candidates for drug development. Bicycles lead product candidate, BT1718, is a Bicycle Toxin Conjugate being investigated in an ongoing Phase I/IIa clinical trial in collaboration with the Centre for Drug Development of Cancer Research UK. Bicycle is headquartered in Cambridge, UK with many key functions and members of its leadership team located in Lexington, MA. For more information, visit bicycletherapeutics.com.

More here:
Bicycle Therapeutics Announces Appointment of Veronica Jordan, Ph.D., to Board of Directors - Business Wire

Biochemistry | College Of Science and Technology | Temple …

Biochemistry is the study of the chemical processes occurring in living matter. As a field, biochemistry is rapidly expanding and highly interdisciplinary. Biochemical concepts and techniques have become the basis for research in physiology, nutrition, environmental and health sciences, and many other disciplines.

The program prepares students for excellence in graduate or medical school, employment in the chemical, biotechnological, or pharmaceutical industries. The degree is a terrific stepping stone for graduate programs in Biochemistry, Bioengineering, Biotechnology, Cell Biology, and many other related fields.

The program consists of basic courses in calculus, biology, chemistry and physics. Advanced courses in both Biology and Chemistry are included, along with specialty Biochemistry courses offered jointly in the Biology and Chemistry departments. Laboratory courses form an important component of the curriculum and include such diverse techniques as PCR, protein purification, gel electrophoresis, computational chemistry, and spectroscopy. This "hands-on" experience is essential to provide the appropriate context for knowledge obtained in the lecture courses.

After completing this program, students should:

Biochemistry Advising Sheets and Flowcharts

Department of Biology

Department of Chemistry

Biochemistry Program Requirements

Read this article:
Biochemistry | College Of Science and Technology | Temple ...

Ling Yang, PhD | Lewis Katz School of Medicine at Temple …

Research Interests

Our laboratory utilizes both computational and experimental biology to identify and characterize previously unknown genes, especially long non-coding RNA genes which drive metabolic disorders including but not limited to fatty liver disease, obesity, diabetes, and hepatocellular carcinoma. We are applying bioinformatics, genetics, genomics, biochemistry, molecular biology, cellular biology, and CRISPR-mediated genome engineering to explore the complex regulatory networks of metabolic disorders, and to translate our findings into novel therapeutics that target RNAs, proteins, or the interactions between RNAs and proteins to treat metabolic diseases.

Current Projects:

1) Long non-coding RNAs(lncRNAs) in metabolic diseases

The lncRNAs are an emerging and rapidly-growing class of functional genomic elements, and a number have been shown to regulate fundamental biological processes, but the scope of their influence in metabolic disorders remains unclear. Identifying and characterizing metabolically-relevant lncRNAs will be crucial to obtaining a better understanding the pathophysiology of metabolic diseases.

2) RNA or RNA targeted therapies to treat metabolic diseases

Our current therapeutic options for metabolic diseases such as fatty liver disease, obesity, and diabetes are very limited, partly due to the gaps in our understanding of metabolism and metabolic pathophysiology. The lncRNA metabolic regulators characterized in our laboratory will provide novel therapeutic targets for metabolic diseases.

3) Multi-Omics approach to dissect the pathological process of metabolic diseases

Recent advances in genomics, transcriptomics, proteomics, metabolomics, and computational biology have made the 21st century a golden age for bioscience research. With the rapid growth of biological data, our laboratory applies both computational and experimental approaches to understand the complex metabolic network of human health and diseases.

View PubMed Publications

Yang L., Li P., Yang W., Ruan X., Zhu J., Cao H. Integrative Transcriptome Analyses of Metabolic Responses in Mice Define Pivotal LncRNA Metabolic Regulators. (Cell Metabolism 2016; 24(4):627-639)

Ruan X., Li P., Cangelosi A., Yang L., Cao H. A Fasting-induced Long Non-coding RNA Regulates Hepatic Glucokinase Expression and Glycogen Storage. (Cell Reports 2016; 14(8):1867-75)

Li P.*, Ruan X.*, Yang L.*, Kiesewetter K., Zhao Y., Luo H., Chen Y., Gucek M., Zhu J., Cao H. A Liver-Enriched Long Non-Coding RNA, lncLSTR, Regulates Systemic Lipid Metabolism in Mice. *equal contribution. (Cell Metabolism 2015; 21(3):455-67)

Yang L., Zhang Y., Wang L., Fan F., Zhu L., Li Z., Ruan X., Huang H., Wang Z., Huang Z., Huang Y., Yan X., Chen Y. Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22. (Journal of Hepatology 2010; 53(2): 339-347)

Read the original post:
Ling Yang, PhD | Lewis Katz School of Medicine at Temple ...

What Is Biochemistry? – Introduction and Overview

Biochemistry is the science in which chemistry is applied to the study of living organisms and the atoms and molecules which comprise living organisms. Take a closer look at what biochemistry is and why the science is important.

Biochemistry is the study of the chemistry of living things. This includes organic molecules and their chemical reactions. Most people consider biochemistry to be synonymous with molecular biology.

The principal types of biological moleculesor biomolecules are:

Many of these molecules are complex molecules called polymers, which are made up of monomer subunits. Biochemical molecules are based on carbon.

Many biochemists work in chemistry labs. Some biochemists may focus on modeling, which would lead them to work with computers. Some biochemists work in the field, studying a biochemical system in an organism. Biochemists typically are associated with other scientists and engineers. Some biochemists are associated with universities and they may teach in addition to conducting research. Usually, their research allows them to have a normal work schedule, based in one location, with a good salary and benefits.

Biochemistry is closely related to other biological sciences that deal with molecules. There is considerable overlap between these disciplines:

Excerpt from:
What Is Biochemistry? - Introduction and Overview

Global Biochemistry Analyzer Market to Grow at a CAGR of 6 … – Business Wire (press release)

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Biochemistry Analyzer Market 2017-2021" report to their offering.

The global Biochemistry Analyzer market to grow at a CAGR of 6.02% during the period 2017-2021.

The report, Global Biochemistry Analyzer Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The latest trend gaining momentum in the market is modular design of biochemistry analyzer. The fully automatic biochemistry analyzer is used to analyze many biochemical parameters of blood sample like blood glucose, urea, protein, etc., to detect various diseases like kidney, liver, and other metabolic disorders. Therefore, by analyzing these parameters, the biochemistry analyzer helps in diagnosing various health disorders. It is a high performance-based micro-controller inbuilt with the photometric technology.

According to the report, one of the major drivers for this market is growing aging population. The increase in median age due to the reduction in fertility rate and the increase in life expectancy result in the growing aging population. These two demographic effects reflect the change in a country's population with a rising aging and a declining child population.

Key vendors

Other prominent vendors

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation by end-user

PART 07: Geographical segmentation

PART 08: Decision framework

PART 09: Drivers and challenges

PART 10: Market trends

PART 11: Vendor landscape

For more information about this report visit https://www.researchandmarkets.com/research/v5qf2j/global

See the article here:
Global Biochemistry Analyzer Market to Grow at a CAGR of 6 ... - Business Wire (press release)

Biochemistry | Nebraska

At the University of Nebraska's Department of Biochemistry, we are developing the worlds next great scientists and researchers.

They come here to learn from and with our distinguished faculty internationally recognized researchers who work at sciences cutting edge, maintaining externally funded laboratories that investigate an array of exciting questions. They come here because we offer both a strong undergraduate major and a thriving graduate program.

And they come here because many of our significant discoveries are made by undergraduate, graduate, and postdoctoral researchers working closely with our faculty.

We are Nebraska's premier biochemistry program, largely because we have created an engaging environment that positions our students to succeed. The Department is one of only four BIG Ten universities accredited by the American Society for Biochemistry and Molecular Biology (ASBMB). Seniors who pass the ASBMB Accreditation exam are recognized by the professional society has earning a certified degree!

We feature award-winning professional advisers, and incomparable mentorship opportunities. We get students out of the book, and into the lab.

Our faculty treat students as future colleagues, working hand-in-hand on high-impact research projects addressing real-world problems related to areas such as metabolism and metabolic engineering, structural and chemical basis of protein function, molecular mechanisms of disease, plant and microbial biochemistry, and biotechnology.

Our graduates go on to excel in their careers both academic and in private industry focusing their talents on medicine, law, pharmaceutical, bio-technology, agriculture, dental and many other fields.

We are asking exciting questions. Help us answer them.

Let curiosity move you.

Go here to read the rest:
Biochemistry | Nebraska

Comprehensive Analysis on Mobility Aid Devices Market based on types and appli – News.MarketSizeForecasters.com

The ' Mobility Aid Devices market' study Added by Market Study Report, LLC, provides an in-depth analysis pertaining to potential drivers fueling this industry. The study also encompasses valuable insights about profitability prospects, market size, growth dynamics, and revenue estimation of the business vertical. The study further draws attention to the competitive backdrop of renowned market contenders including their product offerings and business strategies.

The Mobility Aid Devices market report is a comprehensive document containing details about the business scenario of this industry. It thoroughly analyzes the production and consumption trends prevailing in the market with respect to various segments.

Request a sample Report of Mobility Aid Devices Market at:https://www.marketstudyreport.com/request-a-sample/2560363?utm_source=Itresearchbrief.com&utm_medium=PSR

Speaking on production aspect, the study encompasses data regarding the manufacturing of product, revenue generated, and margins earned by various product manufacturers over the forecast period. While, with respect to consumption outlook, the report elaborates on product consumption value and product consumption volume. Details regarding the unit cost offered across various regions, alongside the import and export graphs for product are given.

Highlights of the reginal terrain:

An insightful summary of the product outlook:

Ask for Discount on Mobility Aid Devices Market Report at:https://www.marketstudyreport.com/check-for-discount/2560363?utm_source=Itresearchbrief.com&utm_medium=PSR

Elaborating the application spectrum:

Overview of the competitive landscape:

The research report on the Mobility Aid Devices market, in essence, is a collection of data which influence the business scenario of the industry as it analyzes the market from upstream raw materials to downstream customer base, along with the established distribution channel.

For More Details On this Report:https://www.marketstudyreport.com/reports/global-mobility-aid-devices-market-research-report-2020-segment-by-key-companies-countries-types-applications-and-forecast-2021-to-2026

Some of the Major Highlights of TOC covers:

Development Trend of Analysis of Mobility Aid Devices Market

Marketing Channel

Market Dynamics

Methodology/Research Approach

Related Reports:

1. Global Veterinary Test kits Market Research Report 2020, Segment by Key Companies, Countries, Types, Applications and Forecast 2021 to 2026Veterinary Test kits market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.Read More: https://www.marketstudyreport.com/reports/global-veterinary-test-kits-market-research-report-2020-segment-by-key-companies-countries-types-applications-and-forecast-2021-to-2026

2. Global Bench-top Veterinary Biochemistry Analyzers Market Research Report 2020, Segment by Key Companies, Countries, Types, Applications and Forecast 2021 to 2026Bench-top Veterinary Biochemistry Analyzers Market Report covers a valuable source of perceptive information for business strategists. Bench-top Veterinary Biochemistry Analyzers Industry provides the overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elegant description of the value chain and its distributor analysis.Read More: https://www.marketstudyreport.com/reports/global-bench-top-veterinary-biochemistry-analyzers-market-research-report-2020-segment-by-key-companies-countries-types-applications-and-forecast-2021-to-2026

Read More On this Report: https://www.marketwatch.com/press-release/recent-research-detailed-analysis-on-solar-tracker-market-size-with-forecast-to-2025-2020-04-06

Contact Us:Corporate Sales,Market Study Report LLCPhone: 1-302-273-0910Toll Free: 1-866-764-2150 Email: [emailprotected]

The rest is here:
Comprehensive Analysis on Mobility Aid Devices Market based on types and appli - News.MarketSizeForecasters.com

NASA and Square Roots Launch Innovative Research Project to Better Understand the Impact of Induced Stress – PR Newswire (press release)

"Motherhood is extraordinary in many ways. This includes high levels of prolonged stress," says Morad Fareed, Founder and CEO of Square Roots. "NASA is informing us how astronauts cope and rebound from the extreme physical and emotional stress of space flight and how these metabolic responses are applicable to an expectant mother's metabolic responses during pregnancy. Amazing. We can improve the pregnancy experience through science and creativity, and are honored to be working with NASA."

NASA's Nutritional Biochemistry Laboratory, which will manage all aspects of the research project, intends to share the results this research in scientific journals and at scientific conferences and to develop educational materials and outreach efforts designed to further our understanding of the effects of stress on the human metabolome. Square Roots will distribute the findings through its network of government, academia, medicine, business and other partners that are committed to positively influencing maternity health and infant development.

Following the culmination of the analysis, NASA's Nutritional Biochemistry Laboratory will develop educational material to support additional research and outreach efforts. Square Roots believes the findings will be directly relatable to in-utero metabolic responses, and ultimately support the company's ongoing research efforts to advance maternal health and wellness. Through an established network of cross-sector leaders, Square Roots will distribute findings to stakeholders from government, academia, medicine, business and other sectors that influence maternal health.

NASA's Nutritional Biochemistry Laboratory personnel will support all aspects of the research, including documentation and review, data management and analysis, and presentation and publication in scientific venues.

About NASA's Nutritional Biochemistry LaboratoryNASA's Nutritional Biochemistry Laboratory works to keep astronauts healthy from a nutrition perspective. While food is important the nutrients contained in those foods support the underlying biological systems bone, muscle, cardiovascular, vision and more. Optimizing nutrition will help keep astronauts healthy on ISS missions, will enable missions beyond low-Earth orbit, and will have broad implications for terrestrial medicine and the general population.

About Square RootsSquare Roots (www.squareroots.com) is a mission-driven company focused on pregnancy health and wellness. By integrating new technology and scientific findings with intelligent partnerships from medicine to policy to maternal care takers, Square Roots brings needed solutions and resources to the most critical period of life: our beginning. We identify the highest impact programs and tools that have a proven health impact for mothers and coordinate the distribution of these programs and tools between academia, policy, public agencies, and private companies.

Contact: Kayla Keller, 281-682-6212 Sara Gurkin, 202-280-2398 squareroots@sunshinesachs.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nasa-and-square-roots-launch-innovative-research-project-to-better-understand-the-impact-of-induced-stress-300481224.html

SOURCE Square Roots

Home

Continue reading here:
NASA and Square Roots Launch Innovative Research Project to Better Understand the Impact of Induced Stress - PR Newswire (press release)

High school students explore chemistry and biochemistry at Misericordia University’s annual Career Exploration Camp – The Dallas Post

Misericordia University hosted a Chemistry-Biochemistry Sciences Career Exploration Camp in June. High school students participating in the camp are, from left, first row, Kyra Grzymski, Shavertown; Lainey Mentrikoski, Mountain Top; Laura Miller, White Haven; Tyler Mendoza, Wilkes-Barre; Cole Yantiss, Vienna, Va.; Charles Saladino, an associate professor; Beth Haas, an assistant professor; Darren Tomeo, Laflin; Erika Wintersteen, Dallas; Hunter Kline, Dallas and Catherine Falzone, Dallas.

DALLAS Misericordia Universitys Chemistry-Biochemistry Sciences Career Exploration Camp gave high school juniors and seniors a chance to explore careers in cosmetic and food chemistry, alternative energy, the pharmaceutical industries.

Students created nylon fibers, extracted essential oils from orange peels, designed and created batteries, made hand lotion, along with other exciting projects and experiments during the three-day residential camp.

Misericordia University also offered camps in biology, communications and media, literature, occupational therapy and speech-language pathology.

The camp programs provide high school students with an opportunity to explore career fields, experience on campus residential life and interact with faculty and current college students.

For more information about the 2017 Chemistry-Biochemistry Sciences Career Exploration Camp, call Anna Fedor, the assistant professor and chair of the Department of Chemistry and Biochemistry, at 570-674-6769 or at afedor@misericordia.edu.

Misericordia University hosted a Chemistry-Biochemistry Sciences Career Exploration Camp in June. High school students participating in the camp are, from left, first row, Kyra Grzymski, Shavertown; Lainey Mentrikoski, Mountain Top; Laura Miller, White Haven; Tyler Mendoza, Wilkes-Barre; Cole Yantiss, Vienna, Va.; Charles Saladino, an associate professor; Beth Haas, an assistant professor; Darren Tomeo, Laflin; Erika Wintersteen, Dallas; Hunter Kline, Dallas and Catherine Falzone, Dallas.

http://www.mydallaspost.com/wp-content/uploads/2017/06/web1_FOR-PUBLICATION-Chemistry-Biochem.jpgMisericordia University hosted a Chemistry-Biochemistry Sciences Career Exploration Camp in June. High school students participating in the camp are, from left, first row, Kyra Grzymski, Shavertown; Lainey Mentrikoski, Mountain Top; Laura Miller, White Haven; Tyler Mendoza, Wilkes-Barre; Cole Yantiss, Vienna, Va.; Charles Saladino, an associate professor; Beth Haas, an assistant professor; Darren Tomeo, Laflin; Erika Wintersteen, Dallas; Hunter Kline, Dallas and Catherine Falzone, Dallas.

.

See more here:
High school students explore chemistry and biochemistry at Misericordia University's annual Career Exploration Camp - The Dallas Post